Results 111 to 120 of about 2,415 (174)

Antiamnesic and Neurotrophic Effects of Parkia biglobosa (Jacq.) R. Br (Fabaceae) Aqueous Extract on In Vivo and In Vitro Models of Excitotoxicity. [PDF]

Behav Neurol
Kandeda AK, Foutse LY, Tongoue C, Djientcheu JP, Dimo T.   +4 more
europepmc   +1 more source

A Case Report of Abdominal Myoclonus Following Anterior Cerebral Artery Stroke. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Nokhrina K, Wold J, Raghavan M, Lamotte G.   +3 more
europepmc   +1 more source

Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and "Smart Drug" Use and Misuse. [PDF]

Biology (Basel)
Schifano F, Bonaccorso S, Arillotta D, Corkery JM, Floresta G, Papanti Pelletier GD, Guirguis A.   +6 more
europepmc   +1 more source

Topiramate-Responsive Myoclonic Status Epilepticus in a Child with Progressive Myoclonus Epilepsy Due to Neuronal Ceroid Lipofuscinosis Type 8: A Case Report. [PDF]

Yonago Acta Med
Tsuchie H, Kawanami Y, Yoshino G, Okanishi T, Maegaki Y.   +4 more
europepmc   +1 more source

Development and Characterization of Heparin-Pullulan Liposomal Nano-Gel for Enhanced Silymarin Delivery in Dementia Therapy: In Vivo Evaluation in Albino Mice. [PDF]

Pharmaceutics
Mushtaq A, Shah HS, Kamran SH, Gohar UF, Neculoiu CD, Podasca PC, Moga MA, Nicolau AC.   +7 more
europepmc   +1 more source

An unexpected discovery of a novel potentially pathogenic APP gene variant: a case report of slowly progressive Alzheimer's disease with prominent cerebral amyloid angiopathy. [PDF]

Front Neurosci
Sykora M, Harmackova M, Parobkova E, Rusina R, Matěj R.   +4 more
europepmc   +1 more source

Alzheimer's Disease: The Current and Emerging Treatment Approaches. [PDF]

Behav Neurol
Pang R, Jia Q, Ma C, Li T, Bi W, Wang H, Liu R, Chen P, Lee ES, Jiang HB.   +9 more
europepmc   +1 more source

Efficacy and safety of anti-inflammatory drug-assisted treatment of symptoms in patients with schizophrenia: a meta-analysis. [PDF]

BMC Psychiatry
Li H, Shen H, Duan X, Guo M, Liu X.
europepmc   +1 more source

HSP₇₀ Modulators for the Correction of Cognitive, Mnemonic, and Behavioral Disorders After Prenatal Hypoxia. [PDF]

Biomedicines
Aliyeva O, Belenichev IF, Bilai I, Duiun I, Makyeyeva L, Oksenych V, Kamyshnyi O.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antimyoclonic Action of Piracetam

Clinical Neuropharmacology, 1986
Five patients with myoclonus were treated with oral piracetam (8-9 g/day). All patients had action-sensitive and/or stimulus-sensitive myoclonus and enhanced amplitude of somatosensory evoked potentials. Piracetam produced a marked reduction of the myoclonus in the five subjects without side effects.
J A, Obeso, J, Artieda, M R, Luquin, J, Vaamonde, J M, Martínez Lage   +4 more
openaire   +2 more sources